知镜 Cognispect · 医学文献与研究工作台

Translational science in modern gynecologic oncology trials.

Arend RC, Dave D, Cosgrove CM, Kohn E, Simpkins F, Adams SF, Nasioudis D, Sood AK.
Gynecologic oncology · 2026-11-12 · PMID 43019614

文献摘要

Translational science is integral in deciding who would benefit the most from novel therapeutics in gynecologic oncology, yet the specimens, assays, and the data behind them are often handled inconsistently as the translational endpoints are planned late. Clinical trials involving PARP-inhibitors, immune checkpoint inhibitors (ICIs), and antibody-drug conjugates in ovarian, endometrial, and cervical cancer show that a biomarker can serve as an eligibility criterion, a stratification factor, a pharmacodynamic measure, or an exploratory tool. This review presents an operational framework for integrating translational science into the trial designs from the outset. We define exploratory, integrated, and integral biomarker tiers and tie each to analytical validation, clinical validation, and level of evidence. It proposes minimum standards for tissue and blood biospecimen collection, adequacy, sampling schedule depending on specimen type, pre-analytical variables, clinical annotation, and reporting with BRISQ, SPREC, and the BloodPAC technical data elements. We also cover newer techniques like ctDNA, addressing their intended use, tumor-informed versus tumor-naive assays, and sampling for minimal residual disease. We then review genomic, transcriptomic, spatial, single-cell, proteomic, metabolomic, and functional platforms, and why discovery should not be treated as validation for modern gynecologic oncology trials. Additionally, maintaining standards for data integration, reproducibility, NIH data sharing in NCI-sponsored, industry-sponsored, and institutional trials is crucial. Ultimately, adaptive master protocols and ctDNA-guided trial designs are discussed as future directions as translational endpoints deserve the same prospective planning as the primary clinical endpoint.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。